ABSTRACT
INTRODUCTION
Myelolipoma is a benign tumor composed of mature adipose tissue and hematopoietic elements that typically arises in the adrenal glands, and involvement of the anterior abdominal region is extremely uncommon. We report a rare case of myelolipoma arising in the subxiphoid preperitoneal region adjacent to the site where a sternum-lifting device had been placed during previous surgery.
CASE PRESENTATION
A 62-year-old man had undergone extended thymectomy for thymoma associated with myasthenia gravis at the age of 39. The procedure was performed via bilateral video-assisted thoracoscopic surgery using a sternum-lifting technique. The tumor was classified as Masaoka stage III, and postoperative radiotherapy was administered. No recurrence was observed during 13 years of follow-up. Ten years after completion of follow-up, CT performed for an unrelated condition incidentally revealed a slowly enlarging 65 × 40-mm mass in the preperitoneal space, adjacent to the previous surgical site where a sternum-lifting device had been placed. MRI demonstrated a fat-containing component within the lesion, and the differential diagnosis included liposarcoma and teratoma. Complete surgical resection was therefore planned. A midline incision extending caudally from the xiphoid process was made, and en bloc resection of the tumor with the involved peritoneum was performed via laparotomy. Histopathological examination revealed mature adipose tissue admixed with hematopoietic elements, confirming the diagnosis of myelolipoma.
CONCLUSIONS
This unique case of extra-adrenal myelolipoma highlights the importance of MRI-based qualitative assessment for tumors arising at unusual sites and underscores the need to include extra-adrenal myelolipoma in the differential diagnosis of fat-containing lesions occurring at previous surgical sites.
KEYWORDS: extra-adrenal myelolipoma, preperitoneal space, secondary surgery, previous surgical site, thymoma, video-assisted thoracoscopic surgery
Abbreviations
- FDG
fluorodeoxyglucose
- FSI
fat-suppression image
- SUVmax
maximum standardized uptake value
- T1WI
T1-weighted image
- T2WI
T2-weighted image
INTRODUCTION
Myelolipoma is a rare benign tumor composed of mature adipose tissue and hematopoietic elements that most commonly arises in the adrenal glands. Extra-adrenal myelolipomas are uncommon, and their occurrence in the anterior abdominal region is exceedingly rare. Furthermore, the development of this tumor at a previous surgical site has rarely been described. We report a case of preperitoneal myelolipoma that developed adjacent to a previous surgical site following video-assisted thoracoscopic surgery for thymoma. The diagnostic challenges and the presumed etiology of this unusual case are discussed.
CASE PRESENTATION
A 39-year-old man underwent surgery for thymoma associated with myasthenia gravis. The procedure consisted of bilateral video-assisted thoracoscopic extended thymectomy using a sternum-lifting technique. Thoracoscopic access ports were placed at 3 sites in each hemithorax, and an additional small subxiphoid incision was made for sternum lifting (Fig. 1). The resected thymoma was classified as Masaoka stage III because of invasion into the mediastinal pleura and pericardium. The surgical margin was pathologically positive, and postoperative radiotherapy to the anterior mediastinum was administered at a total dose of 50 Gy. Follow-up was discontinued 13 years after surgery, at which time no evidence of recurrence was observed.
Fig. 1. Previous surgical site incisions. During the initial surgery, thoracoscopic ports were inserted in the fourth, fifth, and seventh intercostal spaces bilaterally along the anterior axillary line, as well as in the subxiphoid region, as illustrated.

At 62 years of age, 23 years after the initial surgery, the patient presented to a local clinic with lower extremity pain and was subsequently referred to our hospital, where he was diagnosed with lumbar spinal canal stenosis and spondylolisthesis. CT performed during this evaluation incidentally revealed a 65 × 40-mm mass in the preperitoneal space beneath the xiphoid process, near the previous surgical site. A retrospective review of prior CT images demonstrated subtle changes at the same site beginning 8 years after the initial surgery, and the lesion exhibited indolent growth over time. Compared with the most recent CT obtained 10 years earlier, the lesion had enlarged (Fig. 2). MRI demonstrated a lesion with mixed low- and high-signal intensities on both T1WIs and T2WIs. The signal intensity decreased on FSIs, suggesting the presence of adipose tissue (Fig. 3). Because the lesion was a progressively enlarging fat-containing tumor, liposarcoma was included in the differential diagnosis. Its midline location and the presence of focal calcification further raised the possibility of teratoma. Angiomyolipoma and extramedullary hematopoiesis were also considered in the differential diagnosis. However, angiomyolipoma was considered unlikely because it typically arises in the kidney or liver and because characteristic vascular features were absent. Extramedullary hematopoiesis was considered unlikely because the patient had no clinical findings suggestive of hematologic disease, such as anemia or splenomegaly. PET/CT demonstrated FDG uptake confined to the tumor, with a SUVmax of 3.0.
Fig. 2. CT findings. (A) Five years after the initial surgery, no lesion was identified in the subxiphoid region. (B) Eight years after the initial surgery, a retrospective review revealed a very small area of increased fat attenuation in the subxiphoid region (yellow circle). (C) Thirteen years after the initial surgery, a retrospective review demonstrated a slight increase in the size of the subxiphoid lesion (yellow circle). (D) Twenty-three years after the initial surgery, the lesion had clearly enlarged (yellow circle). (E) Calcified components were observed within the lesion (red arrow). (F) A sagittal CT image obtained 23 years after the initial surgery, demonstrating the lesion in the subxiphoid region (yellow circle).
Fig. 3. MRI findings. (A) T1WI demonstrated a lesion with mixed low- and high-signal intensities (yellow circle). (B) T2WI demonstrated a lesion with mixed low- and high-signal intensities (yellow circle). (C) On FSI, the signal intensity of the lesion decreased, indicating the presence of adipose tissue (yellow circle).
FSI, fat-suppression image; T1WI, T1-weighted image; T2WI, T2-weighted image
The patient’s medical history was otherwise unremarkable except for thymoma associated with myasthenia gravis. After extended thymectomy, he remained free of myasthenic symptoms while receiving prednisolone 10 mg every other day. He had a smoking history of 20 cigarettes per day for 18 years. His Eastern Cooperative Oncology Group performance status was 0.
Given the slow but progressive growth of the tumor, liposarcoma or teratoma could not be excluded based on MRI findings, and FDG uptake was observed on PET/CT. Therefore, surgical resection was planned. Surgery was performed under general anesthesia with the patient in the supine position. A 10-cm midline skin incision extending caudally from the xiphoid process was made, and the xiphoid process was subsequently excised. The tumor was surrounded by adipose tissue and was located in the preperitoneal space just beneath the xiphoid process, adjacent to the site where a sternum-lifting device had been placed during the prior surgery. The tumor was faintly palpable on manual examination. Foreign materials, such as surgical sutures, bone fragments, or scar tissue from the previous surgery, were not identified. Because the caudal aspect of the tumor was densely adherent to the peritoneum, en bloc resection of the tumor with the involved peritoneum was undertaken to achieve an adequate caudal margin. Consequently, the procedure was converted to laparotomy.
Macroscopically, the excised tumor was firm and brownish on the surface. The cut surface was hemorrhagic and measured 6.5 cm at its greatest dimension. Microscopically, trilineage hematopoietic cells, including megakaryocytes, granulocytes, and erythroblasts, were observed within mature adipose tissue (Fig. 4). A small amount of trabecular bone formation was noted in the peripheral region of the tumor. The lesion was well circumscribed and clearly separated from the surrounding normal tissue. Hematopoietic cells were confined to the lesion and were not identified outside it. No atypical cells, including lipoblasts, were identified in the tumor. Based on the histopathological findings, the lesion was diagnosed as myelolipoma. Because the findings in the hematoxylin and eosin staining were typical and diagnostic, immunohistochemistry was not required. No thymoma components were identified. The tumor was well demarcated from the surrounding tissues, and no invasion of the peritoneum or rectus abdominis muscle was observed. Pathological examination confirmed complete resection.
Fig. 4. Pathological findings. (A) The lesion had a smooth brown outer surface and was firm on palpation. The center of the tumor appeared red because of suboptimal fixation. (B) Hematoxylin and eosin staining. A lower-power view showing a well-circumscribed mass composed of mature adipocytes and hematopoietic elements (scale bar: 500 μm). (C) A higher-power view demonstrated trilineage hematopoiesis, including megakaryocytes, granulocytes, and erythroblasts (scale bar: 50 μm).
DISCUSSION
The reported incidence of adrenal myelolipoma at autopsy ranges from 0.08% to 0.4%, indicating that it is a relatively uncommon tumor.1) Myelolipoma most commonly arises in the adrenal glands, and extra-adrenal myelolipomas account for approximately 10%–15% of all cases. Among extra-adrenal lesions, the presacral region is the most frequently reported site, followed by the liver, mediastinum, and retroperitoneum.2,3)
Myelolipoma arising in the anterior abdominal wall or preperitoneal space is extremely uncommon, and cases associated with prior surgical sites are also very limited. To our knowledge, only a single case involving the anterior abdominal wall at a previous surgical site has been reported in the literature by Pillay.4) In that report, the lesion developed in the midline of the anterior abdominal wall over a decade after open mesh herniorrhaphy. Both the present case and the case reported by Pillay shared the feature that tumor formation became apparent about a decade after the initial surgery, suggesting a slowly progressive process over many years. In contrast, the lesion in the case reported by Pillay arose adjacent to nonabsorbable mesh, whereas no nonabsorbable material had been used at the tumor site in the present case.
Initially, recurrence of thymoma was suspected based on the CT findings. However, subsequent qualitative evaluation using MRI revealed that the tumor contained adipose tissue. At that stage, given that the lesion was a progressively enlarging midline mass containing fat and focal calcification, the main differential diagnoses included teratoma and liposarcoma. Table 1 summarizes the imaging features of the major differential diagnoses in the present case.1,3,5–15)
Table 1. Imaging features of the major differential diagnoses in the present case.
| Diagnosis | CT findings | MRI findings | PET/CT findings | Findings relevant to the present case |
|---|---|---|---|---|
| Myelolipoma1,3,5–7) | Well-defined fat-containing mass with hematopoietic tissue; ± calcification/hemorrhage | High T1 and intermediate-to-high T2 signal; suppressed on fat-suppressed images | Mild FDG uptake; little to no uptake in the fatty component | Fat-containing lesion with mild FDG uptake |
| Well-differentiated liposarcoma8,9) | Lobulated heterogeneous mass with fatty areas | Predominantly high T1 signal with thick septa and nodular soft-tissue components; heterogeneous T2 signal (“triple sign”) | Mild to moderate FDG uptake | Progressive enlargement and nonfatty soft-tissue components |
| Mature teratoma 8,10–12) | Fat-containing lesion with calcification, soft-tissue, and occasionally cystic components | Mixed-intensity lesion with fat, fluid, soft tissue, and calcification | Usually low FDG uptake | Midline location and focal calcification |
| Immature teratoma8,12,13) | Heterogeneous lesion with fat, calcification, and solid components | Mixed signal intensity with irregular solid portions and less well-defined internal architecture | Moderate to high FDG uptake | Progressive enlargement, midline location, and focal calcification |
| Recurrent thymoma12,14,15) | Soft-tissue mass in the anterior mediastinum or prior operative field | Low to intermediate T1 signal and intermediate-to-high T2 signal; usually lacks macroscopic fat | Mild to moderate FDG uptake | History of thymoma resection and development in the prior operative field |
FDG, fluorodeoxyglucose
The exact pathogenesis of extra-adrenal myelolipoma remains uncertain.5,16,17) Several mechanisms have been proposed, and the most widely accepted theory is metaplastic transformation of mesenchymal cells induced by various stimuli, including inflammation, infection, and stress.1,18–20) Another hypothesis suggests that microfractures of the vertebral bodies may allow hematopoietic tissue to extend into the paravertebral spaces. Such ectopic hematopoietic tissue may contain pluripotent stem cells capable of giving rise to extra-adrenal myelolipomas.21)
In the present case, the tumor developed adjacent to the previous surgical site in the subxiphoid region where a sternum-lifting device had been placed. It is therefore conceivable that surgical trauma and subsequent chronic inflammation triggered metaplastic transformation of local mesenchymal cells. Although reports of extra-adrenal myelolipomas arising at prior surgical sites are rare, it is noteworthy that the other anterior abdominal wall lesion reported by Pillay also developed at the site of a previous open mesh herniorrhaphy performed more than a decade earlier. Another possible explanation is that a small amount of bone marrow tissue was displaced during the sternal elevation procedure and subsequently implanted into the surrounding peritoneal tissues. However, because no bone-disrupting event was documented in the operative record, the likelihood of this hypothesis appears to be limited. Any association between tumor development and chronic mechanical irritation, surgical trauma, or ectopic implantation of bone marrow tissue remains speculative, and no direct evidence supporting these mechanisms was obtained in the present case.
In this case, although radiotherapy had been administered to the anterior mediastinum after the previous surgery, the subxiphoid region was outside the irradiation field. Therefore, any effect of prior radiotherapy was considered negligible.
For adrenal myelolipomas, conservative management is generally recommended for asymptomatic tumors smaller than 4 cm.22,23) In contrast, surgical resection is considered for tumors measuring 6 cm or more, or for those demonstrating significant growth, because of the risks of spontaneous rupture or hemorrhage.23,24) Owing to their rarity, no standardized treatment strategy has been established for extra-adrenal myelolipomas, and conservative management has been reported only for small, asymptomatic presacral lesions.25) Surgical resection is recommended for symptomatic or progressively enlarging lesions, despite the absence of documented malignant transformation.
In the present case, the tumor demonstrated an indolent growth pattern, and based on imaging findings, the possibility of thymoma recurrence, teratoma, or malignant tumors such as liposarcoma could not be completely excluded. Therefore, surgical resection was ultimately considered an appropriate management strategy. This case highlights the importance of considering a broad differential diagnosis and carefully determining the indication for surgery when a lesion develops at a previous surgical site, rather than immediately concluding recurrence.
CONCLUSIONS
We report a case of extra-adrenal myelolipoma arising in the subxiphoid preperitoneal region at the site where a sternum-lifting device had been placed during video-assisted thoracoscopic extended thymectomy performed 23 years earlier. This unique case highlights the importance of MRI-based qualitative assessment for tumors arising at unusual sites and underscores the need to include extra-adrenal myelolipoma in the differential diagnosis of fat-containing lesions occurring at previous surgical sites.
ACKNOWLEDGMENTS
This manuscript was prepared with the assistance of ChatGPT (OpenAI) for language refinement. The authors reviewed, revised, and approved the final content.
DECLARATIONS
Funding
The authors declare that no funding was received for this study.
Authors’ contributions
CN collected the clinical data and edited the manuscript.
SKu performed the surgery and supervised the writing of the manuscript.
CI performed the histopathological diagnosis.
HOg, TW, and J-iK assisted in the surgery.
TI, KOr, Ska, TK, KOn, YW, TS, HN, HOi, and YO were involved in the clinical management of the patient.
All authors have read and approved the final manuscript and agree to be accountable for all aspects of the work.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article.
Ethics approval and consent to participate
Ethics approval was not required for this case report in accordance with institutional policy.
Consent for publication
Informed consent was obtained from the patient for publication of this case report.
Competing interests
The authors declare that they have no competing interests.
REFERENCES
- 1).Cao J, Huang X, Cui N, et al. Surgical management and outcome of extra-adrenal myelolipomas at unusual locations: a report of 11 cases in a single center. J Bone Oncol 2022; 35: 100438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2).Hakim A, Rozeik C. Adrenal and extra-adrenal myelolipomas - a comparative case report. J Radiol Case Rep 2014; 8: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3).Baker KS, Lee D, Huang M, et al. Presacral myelolipoma: a case report and review of imaging findings. J Radiol Case Rep 2012; 6: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4).Pillay Y. Abdominal wall extra-adrenal myelolipoma, a case report and review of the literature. J Surg Case Rep 2018; 2018: rjy063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5).Shen C, Zhou K, Lai Y, et al. Review of primary extra-adrenal myelolipoma of the thorax. J Surg Res 2017; 207: 131–7. [DOI] [PubMed] [Google Scholar]
- 6).Rowe SP, Javadi MS, Solnes LB, et al. Appearance of adrenal myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose positron emission tomography-computed tomography. World J Nucl Med 2017; 16: 271–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7).Kenney PJ, Wagner BJ, Rao P, et al. Myelolipoma: CT and pathologic features. Radiology 1998; 208: 87–95. [DOI] [PubMed] [Google Scholar]
- 8).Shahrzad M, Le TS, Silva M, et al. Anterior mediastinal masses. AJR Am J Roentgenol 2014; 203: W128–38. [DOI] [PubMed] [Google Scholar]
- 9).O’Regan KN, Jagannathan J, Krajewski K, et al. Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment. AJR Am J Roentgenol 2011; 197: W37–43. [DOI] [PubMed] [Google Scholar]
- 10).Moeller KH, Rosado-de-Christenson ML, Templeton PA. Mediastinal mature teratoma: imaging features. AJR Am J Roentgenol 1997; 169: 985–90. [DOI] [PubMed] [Google Scholar]
- 11).Duc VT, Thuy TTM, Bang HT, et al. Imaging findings of three cases of large mediastinal mature cystic teratoma. Radiol Case Rep 2020; 15: 1058–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12).Watanabe T, Shimomura H, Mutoh T, et al. Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors. Surg Today 2019; 49: 143–9. [DOI] [PubMed] [Google Scholar]
- 13).Strollo DC, Rosado-de-Christenson ML. Primary mediastinal malignant germ cell neoplasms: imaging features. Chest Surg Clin N Am 2002; 12: 645–58. [DOI] [PubMed] [Google Scholar]
- 14).Marom EM. Imaging thymoma. J Thorac Oncol 2010; 5(Suppl 4): S296–303. [DOI] [PubMed] [Google Scholar]
- 15).Strange CD, Ahuja J, Shroff GS, et al. Imaging evaluation of thymoma and thymic carcinoma. Front Oncol 2022; 11: 810419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16).Ye Z, Wu X, Fang C, et al. Clinical characteristics and surgical management of rare thoracic myelolipoma: experience from a single center with literature review. World J Surg Oncol 2025; 23: 408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17).Grignon DI, Shkrum MJ. Extra-adrenal myelolipoma. Arch Pathol Lab Med 1989; 113: 52–4. [PubMed] [Google Scholar]
- 18).Fowler MR, Williams RB, Alba JM, et al. Extra-adrenal myelolipomas compared with extramedullary hematopoietic tumors: A case of presacral myelolipoma. Am J Surg Pathol 1982; 6: 363–74. [DOI] [PubMed] [Google Scholar]
- 19).Giffen HK. Myelolipoma of adrenals: report of 7 cases. Am J Pathol 1947; 23: 613–25. [PMC free article] [PubMed] [Google Scholar]
- 20).Xiong Y, Wang Y, Lin Y. Primary myelolipoma in posterior mediastinum. J Thorac Dis 2014; 6: E181–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21).Fonda P, de Santiago E, Guijarro M, et al. Mediastinal myelolipoma with leukocytosis. BMJ Case Rep 2013; 2013: bcr2013010349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22).Shenoy VG, Thota A, Shankar R, et al. Adrenal myelolipoma: controversies in its management. Indian J Urol 2015; 31: 94–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23).Zeiger MA, Thompson GB, Duh QY, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations. Endocr Pract 2009; 15: 450–3. [DOI] [PubMed] [Google Scholar]
- 24).Liu HP, Chang WY, Chien ST, et al. Intra-abdominal bleeding with hemorrhagic shock: a case of adrenal myelolipoma and review of literature. BMC Surg 2017; 17: 74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25).Andriandi, Cleven AHG, Hanff DF, et al. Presacral myelolipoma, case report and literature review. Ann Med Surg (Lond) 2020; 57: 274–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets supporting the conclusions of this article are included within the article.



